Open Accessibility Menu

Cynthia Wetmore,MD,PhD

Primary Service
  • Pediatric Hospital Medicine
Areas of Interest Newborn care, acute medical care, hematology/oncology, genetics, quality improvement and clinical education and research
  • Bachelor of Arts in History of Science, Harvard University, Cambridge, MA
Medical School
  • Medical Degree, University of Minnesota, Minneapolis, MN
  • Pediatric Residency, University of Minnesota, Minneapolis, MN
  • Pediatric Residency, Mayo Clinic, Rochester, MN
  • Clinical Fellowship in Hematology/Oncology/BMT, St. Jude Children’s Research Hospital, Memphis, TN

Board certification
Pediatric Medicine, American Board of Pediatrics
Pediatric Hematology/Oncology

Philosophy of care
I believe that parents are the experts regarding their child. My role as a medical provider is to partner with parents and provide them anticipatory guidance, help their child recover from an acute illness, and devise the best treatment strategy as they move forward. My goal is to ease the stress of being in the hospital for both the parents and the child.

Why Dr. Wetmore went into medicine
I was a History and Philosophy of Science major in college. I went into medicine because I wanted to learn more about the brain, as the ‘seat of the soul.’ I love the science of medicine and applying medical advances to improve the lives of my patients and their families.

Favorite advice to give patients
My favorite advice to give to patients is to enjoy your parenting adventure and listen to what your child says and does not say. Really sit and listen to them without distraction at least once per day. Your love and attention mean more to them than anything else.

Roseville, MN

I am very excited to live in Duluth as I love to hike, run, explore and have outdoor adventures with my dog, friends and family. In my spare time, I enjoy reading, cooking, traveling, knitting and growing finicky plants (e.g., roses outside and orchids inside).

Awards & Recognitions

2019 Recognized as Arizona Business Journal’s Most Influential Woman

2016 Career Mentor of the Year, Department of Pediatrics, Emory University School of Medicine

2016 Wilbur Fisk Glenn Jr. Distinguished Faculty Chair for Clinical and Translational Research, Children’s Healthcare of Atlanta

2004 Sontag Foundation Distinguished Scientist Award

2003 Award for Excellence in Teaching, Mayo College of Medicine


  1. Colvin Wanshura LE, Galvin KE, Ye H, Fernandez-Zapico ME, Wetmore C. Sequential activation of Snail1 and N-myc modulates Sonic hedgehog induced transformation of neural cells. Cancer Res. 2011 Aug 1; 71(15):5336-45. Epub 2011 Jun 6. PMID 21646478
  2. Wetmore C, Boyett J, Li S, Bendel A, Gajjar A, Orr BA. Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in children. Neuro Oncol 2015. Jun;17(6):882-8 Epub 2015 Feb 16. PMID: 25688119
  3. Wetmore C, Daryani VM, Billups CA, Boyett JM, Leary S, Tanos R, Goldsmith KC, Stewart CF, Blaney SM, Gajjar A. Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: A Children’s Oncology Group Study ACNS1021. Cancer Med 2016 Apr 25. PMID:27109549
  4. Wetmore C. Forgoing conventional therapy in Phase I oncology research: Don’t forget about the children, American Journal of Bioethics 17(4):72-73, 2017
  5. Hanson HA, Hay WW, Tobin JN, Barkin SL, Atkins M, Karagas MR, Dozier AM, Wetmore C, Konstan MW, Heubl JE. Opportunities for life course research through the integration of data across Clinical and Translational Research Institutes. J Clin Transl Sci. 2(3):156-62. 2018. PMID: 30370067
  6. He C, Xu K, Zhu X, Dunphy PS, Gudenas B, Lin W, Twarog N, Hover LD, Kwon CH, Kasper LH, Zhang J, Li X, Dalton J, Jonchere B, Mercer KS, Currier DG, Caufield W, Wang Y, Xie J, Broniscer A, Wetmore C, Upadhyaya SA, Qaddoumi I, Klimo P, Boop F, Gajjar A, Zhang J, Orr BA, Robinson GW, Monje M, Freeman BB III, Roussel MF, Northcott PA, Chen T, Rankovic Z, Wu G, Chiang J, Tinkle CL, Shelat AA, BakerSJ. Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma. Nat Commun. 2021; 12: 4089. Published online 2021 Jul 2. doi: 10.1038/s41467-021-24168-8. PMCID: PMC8253809